Saba Ansari, MD
Geriatric Medicine · Mason, OHNPI 1972506855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $680 and has fallen 97.5% since, to $17 in 2024.
Across 71 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$184
- AbbVie$149
- Lilly USA, LLC$127
- AstraZeneca$113
- Amgen$106
- Novo Nordisk$81
- plus $699 from 22 others
What the payments were for
- Food & beverage$1,44499%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $184 |
| AbbVie | 7 | $149 |
| Lilly USA, LLC | 10 | $127 |
| AstraZeneca | 4 | $113 |
| Amgen(2 entities) | 2 | $106 |
| Novo Nordisk | 5 | $81 |
| Abbott | 3 | $73 |
| Amarin Pharma, Inc. | 4 | $72 |
| Akcea Therapeutics, Inc. | 1 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Novartis | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $29 |
| Merck | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 2 | $25 |
| Bayer | 2 | $25 |
| Urovant Sciences Inc | 1 | $25 |
| Almatica Pharma LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Renalytix AI, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$113
How this compares
$1,460 in reported general payments places this provider in the 80th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 874 | $408,232 |
| NuplazidPimavanserin Tartrate | 13 | $68,625 |
| XifaxanRifaximin | 28 | $60,192 |
| XareltoRivaroxaban | 147 | $59,567 |
| OzempicSemaglutide | 49 | $50,556 |
| TrulicityDulaglutide | 80 | $45,578 |
| JardianceEmpagliflozin | 114 | $43,819 |
| JanuviaSitagliptin Phosphate | 63 | $28,209 |
| ErtapenemErtapenem Sodium | 45 | $27,856 |
| Atorvastatin Calcium | 1,491 | $27,655 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $25,435 |
| MyrbetriqMirabegron | 61 | $21,883 |
| Divalproex Sodium | 428 | $18,853 |
| Potassium Chloride | 845 | $18,550 |
| Pantoprazole Sodium | 809 | $17,261 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $127 | $62,114110 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $17 | $60,19228 claims |
| Johnson & JohnsonXarelto | $12 | $59,567147 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $31 | $51,049128 claims |
| Novo NordiskOzempic | $81 | $50,55649 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $184 | $46,17289 claims |
| MerckJanuvia | $26 | $28,20963 claims |
| AbbVieCreon, Linzess | $149 | $21,05358 claims |
| NovartisEntresto | $41 | $13,77238 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $15 | $9,94012 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $25 | $7,99111 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $7,969561 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Mason
- Meenakshi PatelCenterville$644K
- Daniel CannoneWadsworth$423K
- Babak TousiCleveland$215K
- Brinder VijWest Chester$92K
- Sean CannoneCopley$74K
- Tai-Chi KwokWooster$26K
- James FidelholtzCincinnati$15K
- Rodney IsonCanal Fulton$10K
- Ronan FactoraCleveland$9K
- Gurjeet KahlonCenterville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.